CeGaT GmbH

Learn about the plasma proteome of cancer patients, before and after vaccination. Biomarker discovery, driven by machine learning on proteogenomic data.

Join our Biomarker Discovery Summit with talks from Dr. Dr. Saskia Biskup (CeGaT GmbH), Marios Dimitriou, PhD, and Dr. Lutz Priebe (both Olink), and Sina Silvia Angenendt (University of Tübingen).

The plasma proteome of cancer patients, before and after vaccination. Biomarker discovery, driven by machine learning on proteogenomic data. This is on the agenda at the CeGaT x Olink Biomarker Discovery Summit in Tübingen. This event is for researchers in pharma and academia working on biomarker discovery, translational research, and computational approaches to multi-omics data. The program combines expert talks with time for direct exchange with speakers and peers over lunch.

You've measured concentration and purity. But for long-read WGS, that's only part of the picture. Fragment size distribution determines read length – and it's not captured by standard concentration measurements. Download our free Input Guide to find out what else matters.

Download the Long-Read WGS Input Guide The right sequencing provider tells you what your sample can deliver for long-read WGS – before the run starts. Fragment size, purity, and concentration all shape your output. Does your provider assess them independently?

Long-read WGS projects don't fall short because of the sequencer. They fall short because of sample quality – and because output expectations weren't based on a thorough assessment of it. Download our free Input Guide to understand which factors actually determine your results.